Original Research

Safety, tolerability, and pharmacokinetics of single and repeat ascending doses of CHF6001, a novel inhaled phosphodiesterase-4 inhibitor: two randomized trials in healthy volunteers

Mariotti F, Govoni M, Lucci G, Santoro D, Nandeuil MA

International Journal of Chronic Obstructive Pulmonary Disease 2018, 13:3399-3410

Published Date: 18 October 2018